CXCL12 expression as a prognostic marker in 40 low-grade oligodendrogliomas and oligoastrocytomas

被引：0
|
作者：
Pollo, B. [1 ]
Maderna, E. [1 ]
Calatozzolo, C. [1 ]
Gelati, M. [1 ]
Marras, C. [1 ]
Silvani, A. [1 ]
Croci, D. [1 ]
Boiardi, A. [1 ]
Salmaggi, A. [1 ]
机构：
[1] Ist Nazl Neurol C Besta, Milan, Italy
来源：
NEURO-ONCOLOGY | 2006年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：462 / 462
页数：1
相关论文
共 50 条
  • [31] CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma
    Chen, Ruiwan
    Xu, Yafei
    Du, Xiaojing
    Liu, Na
    Li, Yingqin
    He, Qingmei
    Tang, Linglong
    Mao, Yanping
    Sun, Ying
    Chen, Lei
    Ma, Jun
    ONCOTARGETS AND THERAPY, 2015, 8 : 2835 - 2842
  • [32] Prolonged time to tumor progression in low-grade oligoastrocytomas with PDGF-B/PDGFR-beta expression
    Burton, EC
    Lamborn, KR
    Weiss, W
    Perry, A
    VandenBerg, S
    NEURO-ONCOLOGY, 2004, 6 (04) : 315 - 315
  • [33] Clinical implication of CXCL12 expression in gastric cancer
    Ishigami, Sumiya
    Natsugoe, Shoji
    Okumura, Hiroshi
    Matsumoto, Masataka
    Nakajo, Akihiro
    Uenosono, Yoshikazu
    Arigami, Takaaki
    Uchikado, Yasuto
    Setoyama, Tetsuro
    Arima, Hideo
    Hokita, Shuichi
    Aikou, Takashi
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (11) : 3154 - 3158
  • [34] Nitric oxide inhibits CXCL12 expression in neuroinflammation
    Petkovic, Filip
    Blazevski, Jana
    Momcilovic, Miljana
    Stojkovic, Marija Mostarica
    Miljkovic, Djordje
    IMMUNOLOGY AND CELL BIOLOGY, 2013, 91 (06): : 427 - 434
  • [35] Clinical Implication of CXCL12 Expression in Gastric Cancer
    Sumiya Ishigami
    Shoji Natsugoe
    Hiroshi Okumura
    Masataka Matsumoto
    Akihiro Nakajo
    Yoshikazu Uenosono
    Takaaki Arigami
    Yasuto Uchikado
    Tetsuro Setoyama
    Hideo Arima
    Shuichi Hokita
    Takashi Aikou
    Annals of Surgical Oncology, 2007, 14 : 3154 - 3158
  • [36] Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
    Johan A. F. Koekkoek
    Linda Dirven
    Jan J. Heimans
    Tjeerd J. Postma
    Maaike J. Vos
    Jaap C. Reijneveld
    Martin J. B. Taphoorn
    Journal of Neuro-Oncology, 2016, 126 : 347 - 354
  • [37] Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
    Koekkoek, Johan A. F.
    Dirven, Linda
    Heimans, Jan J.
    Postma, Tjeerd J.
    Vos, Maaike J.
    Reijneveld, Jaap C.
    Taphoorn, Martin J. B.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 126 (02) : 347 - 354
  • [38] CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia
    Semaan, Alexander
    Dietrich, Dimo
    Bergheim, Dominik
    Dietrich, Joern
    Kalff, Joerg C.
    Branchi, Vittorio
    Matthaei, Hanno
    Kristiansen, Glen
    Fischer, Hans-Peter
    Goltz, Diane
    VIRCHOWS ARCHIV, 2017, 470 (02) : 185 - 196
  • [39] High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II–III astrocytomas and oligoastrocytomas
    Kimmo J. Hatanpaa
    Tianshen Hu
    Vamsidhara Vemireddy
    Chan Foong
    Jack M. Raisanen
    Dwight Oliver
    Matthew C. Hiemenz
    Dennis K. Burns
    Charles L. White
    L. Anthony Whitworth
    Bruce Mickey
    Martha Stegner
    Amyn A. Habib
    Karen Fink
    Elizabeth A. Maher
    Robert M. Bachoo
    Journal of Neuro-Oncology, 2014, 117 : 183 - 189
  • [40] CXCL12 and CXCL3 Expression in Young Women With Endometrial Cancer
    Badran, Abdul
    Ellis, Patricia
    Dina, Roberto
    MODERN PATHOLOGY, 2015, 28 : 274A - 274A
12345